Thymic atrophy in acute experimental Chagas disease is associated with an imbalance of stress hormones

Annals of the New York Academy of Sciences

Volumn 1262, Issue 1, 2012, Pages 45-50

  Lepletier, Ailin ^a   de Frias Carvalho, Vinícius ^a   Morrot, Alexandre ^b   Savino, Wilson ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Glucocorticoids; Prolactin; Thymic atrophy; Trypanosoma cruzi

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; STRESS HORMONE;

ARTICLE; CHAGAS DISEASE; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; NONHUMAN; PROLACTIN RELEASE; SIGNAL TRANSDUCTION; THYMOCYTE; THYMUS ATROPHY; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 84864141127     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06601.x     Document Type: Article

References (32)

1. Franchimont, D. 2004. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. N.Y. Acad. Sci. 1024: 124-137.
2. Lechner, O. et al. 2000. Glucocorticoid production in the murine thymus. Eur. J. Immunol. 30: 337-346.
3. Coutinho, A.E. & K.E. Chapman. 2011. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 335: 2-13.
4. Mangelsdorf, D.J. et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
5. Adcock, I.M. & G. Caramori. 2001. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 79: 376-384.
6. Oz, H.S. et al. 2002. Effects of immunomodulators on acute Trypanosoma cruzi infection in mice. Med. Sci. Monit. 8: 208-211.
7. Yu-Lee, L.Y. 2002. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res. 57: 435-455.
8. McCann, S.M. et al. 2000. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann. N.Y. Acad. Sci. 917: 4-18.
9. Corbacho, A.M. 2004. Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides. Am. J. Physiol. Endocrinol. Metab. 287: 750-757.
10. Bole-Feysot, C. et al. 1998. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19: 225-268.
11. Stöcklin, E. et al. 1996. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383: 726-728.
12. Savino, W. & M. Dardenne. 2000. Neuroendocrine control of thymus physiology. Endocr. Rev. 21: 412-443.
13. Timsit, J. et al. 1992. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin. Endocrinol. Metabol. 75: 183-188.
14. Kelley, K.W. et al. 1986. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA 83: 5663-5667.
15. Gaufo, G.O. & M.C. Diamond. 1996. Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc. Natl. Acad. Sci. USA 93: 4165-4169.
16. Biswas, R., T. Roy & U. Chattopadhyay. 2006. Prolactin induced reversal of glucocorticoid mediated apoptosis of immature cortical thymocytes is abrogated by induction of tumor. J. Neuroimmunol. 171: 120-134.
17. Krishnanan, N. et al. 2003. Prolactin suppresses glucocorticoid-induced apoptosis in vivo. Endocrinology 144: 2102-2110.
18. Pérez, A.R. et al. 2007. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav. Immun. 21: 890-900.
19. Fontanella, G.H. et al. 2009. Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation. Clin. Exp. Immunol. 157: 291-299.
20. Roggero, E. et al. 2006. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J. Endocrinol. 190: 495-503.
21. Kierszenbaum, F. 2005. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol. 21: 513-516.
22. Savino, W. 2006. The thymus is a common target organ in infectious diseases. PLoS Pathog. 6: 472-483.
23. Roggero, E. et al. 2006. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J. Endocrinol. 190: 495-503.
24. Bertini, R., M. Bianchi & P. Ghezzi. 1988. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167: 1708-1712.
25. Corrêa-de-Santana, E. et al. 2009. Modulation of growth hormone and prolactin secretion in Trypanosoma cruzi-infected mammosomatotrophic cells. Neuroimmunomodulation 16: 208-212.
26. Corrêa-de-Santana, E., F. Pinto-Mariz & W. Savino. 2006. Immunoneuroendocrine interactions in Chagas disease. Ann. N.Y. Acad. Sci. 1088: 274-283.
27. Purton, J.F. et al. 2004. Expression of glucocorticoid expression from 1A promoter correlates to T lymphocyte sensitivity to glucocorticoid-induced cell death. J. Immunol. 173: 3816-3824.
28. van den Brandt, J., D. Wang D & H.M. Reichardt. 2003. Resistance of single-positive thymocytes to glucocorticoid-induced apoptosis is mediated by CD28 signaling. Mol. Endocrinol. 18: 687-695.
29. Leite de Moraes, M.D. et al. 1994. Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi. Scand. J. Immunol. 39: 51-58.
30. Qiao, S. et al. 2008. Age-related synthesis of glucocorticoids in thymocytes. Exp. Cell. Res. 314: 3027-3035.
31. Filipin, M. del V. et al. 2011. Prolactin: does it exert an up-modulation of the immune response in Trypanosoma cruzi-infected rats? Vet. Parasitol. 181: 139-145.
32. Brand, J.M. et al. 2004. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur. Cytokine Netw. 15: 99-104.